Hello everyone! We are Eva and Lara, Interreg volunteers at the University of Ljubljana – Medical Center for Molecular Biology. We are involved in the Interreg project named TRANS-GLIOMA.
The project is based on cooperation between different research institutions in Slovenia (Medical Faculty, National institute of Biology and BioSistematika) and Italy. The main aim of the program is research on the brain tumor glioblastoma, searching for biomarkers of glioblastoma stem cells, which could be a step forward for development of new diagnostics, and to find an appropriate delivery systems of biomarkers to reach cancer cells targetes.
Regarding the project, we are mainly involved in laboratory work, such as production of nanobodies, their purification and marking, immunofluorescence, isolation of exosomes, etc. In the scope of our work we also attended an international conference called Brain tumors: From bench to clinic, held at University Medical Center Ljubljana. The main objective of the conference was to present current methods of treating glioblastoma, give an overview of the current state of glioblastoma research and its progression.
We are enjoying our stay at the laboratory, every week we learn something new and everyone is really nice and supportive. Participating in this project gives us a chance to develop, deepen our knowledge and skills and form new friendships.
Lara: I am a master student at the Faculty of Pharmacy, University of Ljubljana. I am doing my master’s thesis at the Jozef Stefan Institute at the department of biotechnology, where I am doing the research for potential inhibitors of cysteine cathepsins, which are high regulated in some types of cancer. I am thrilled to be a part of TRANS-GLIOMA project's team. The work is diverse and interesting. We are constantly learning and trying new things, solving problems and tackling new challenges.
Eva: I studied Biotechnology at the Faculty of Biotechnology, University of Ljubljana. My master’s thesis is from a field of synthetic biotechnology and how we can use its tools to improve cell therapy used in the treatment of cancer. I am glad to be a part of this project as it also involves developing the potential drugs for glioblastoma, which is the most aggressive cancer that begins within the brain.